E Friedman

998 total citations
23 papers, 861 citations indexed

About

E Friedman is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, E Friedman has authored 23 papers receiving a total of 861 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Oncology and 5 papers in Surgery. Recurrent topics in E Friedman's work include TGF-β signaling in diseases (5 papers), Genetic factors in colorectal cancer (3 papers) and Tumors and Oncological Cases (2 papers). E Friedman is often cited by papers focused on TGF-β signaling in diseases (5 papers), Genetic factors in colorectal cancer (3 papers) and Tumors and Oncological Cases (2 papers). E Friedman collaborates with scholars based in United States, Belgium and Israel. E Friedman's co-authors include Sidney J. Winawer, Leslie I. Gold, Arthur M. Cohen, Mack Lipkin, H L Newmark, David Klimstra, H Y Wang, Diógenes Infante, Paul C. Schroy and Antonio I. Picon and has published in prestigious journals such as Journal of Bacteriology, Journal of Pharmacology and Experimental Therapeutics and Molecular Pharmacology.

In The Last Decade

E Friedman

23 papers receiving 844 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E Friedman United States 14 525 352 217 95 83 23 861
Roman Wernyj United States 10 442 0.8× 179 0.5× 163 0.8× 91 1.0× 164 2.0× 11 800
K Nelson United States 8 487 0.9× 146 0.4× 155 0.7× 168 1.8× 81 1.0× 10 776
Patrizia Vernole Italy 23 615 1.2× 261 0.7× 96 0.4× 191 2.0× 193 2.3× 59 1.0k
T.J. Martin United States 6 628 1.2× 350 1.0× 57 0.3× 199 2.1× 78 0.9× 13 878
Monique Cadrin Canada 18 533 1.0× 102 0.3× 83 0.4× 92 1.0× 69 0.8× 37 1.0k
Shigeaki Kato Japan 6 704 1.3× 392 1.1× 110 0.5× 304 3.2× 99 1.2× 9 1.1k
James Resau United States 15 674 1.3× 167 0.5× 42 0.2× 84 0.9× 72 0.9× 17 1.1k
Andrea N. Moor United States 17 587 1.1× 103 0.3× 69 0.3× 83 0.9× 60 0.7× 20 935
Irit Zurer Israel 10 590 1.1× 357 1.0× 102 0.5× 65 0.7× 228 2.7× 11 951
Susan J. Littman United States 12 510 1.0× 238 0.7× 514 2.4× 64 0.7× 242 2.9× 21 944

Countries citing papers authored by E Friedman

Since Specialization
Citations

This map shows the geographic impact of E Friedman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E Friedman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E Friedman more than expected).

Fields of papers citing papers by E Friedman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E Friedman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E Friedman. The network helps show where E Friedman may publish in the future.

Co-authorship network of co-authors of E Friedman

This figure shows the co-authorship network connecting the top 25 collaborators of E Friedman. A scholar is included among the top collaborators of E Friedman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E Friedman. E Friedman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yocum, Anastasia K., E Friedman, Holli Bertram, Peisong Han, & Melvin G. McInnis. (2023). Comparative mortality risks in two independent bipolar cohorts. Psychiatry Research. 330. 115601–115601. 3 indexed citations
2.
Maor, Sharon, Moshe Z. Papa, Ronit I. Yarden, et al.. (2007). Insulin-like Growth Factor-I Controls BRCA1 Gene Expression through Activation of Transcription Factor Sp1. Hormone and Metabolic Research. 39(3). 179–185. 40 indexed citations
3.
Deng, Xuliang, et al.. (2005). THE KINASE MIRK/DYRK1B MEDIATES CELL SURVIVAL IN PANCREATIC DUCTAL ADENOCARCINOMA. Pancreas. 31(4). 438–438. 3 indexed citations
4.
Picon, Antonio I., et al.. (1998). A subset of metastatic human colon cancers expresses elevated levels of transforming growth factor beta1.. PubMed. 7(6). 497–504. 86 indexed citations
5.
Gürdal, Hakan, et al.. (1995). The expression of alpha 1 adrenoceptor subtypes changes with age in the rat aorta.. Journal of Pharmacology and Experimental Therapeutics. 275(3). 1656–1662. 25 indexed citations
6.
Huang, Fei, Elliot Newman, Dan Theodorescu, Robert S. Kerbel, & E Friedman. (1995). Transforming growth factor beta 1 (TGF beta 1) is an autocrine positive regulator of colon carcinoma U9 cells in vivo as shown by transfection of a TGF beta 1 antisense expression plasmid.. PubMed. 6(12). 1635–42. 46 indexed citations
7.
Gürdal, Hakan, E Friedman, & Michael D. Johnson. (1995). Effects of Dietary Restriction on the Change in Aortic  1-Adrenoceptor Mediated Responses During Aging in Fischer 344 Rats. The Journals of Gerontology Series A. 50A(2). B67–B71. 13 indexed citations
8.
Friedman, E, et al.. (1995). High levels of transforming growth factor beta 1 correlate with disease progression in human colon cancer.. PubMed. 4(5). 549–54. 149 indexed citations
9.
Schnee, Charles L., et al.. (1994). Carcinoid Tumor of the Sacrum. Neurosurgery. 35(6). 1163–1167. 34 indexed citations
10.
Hsu, Stephen, et al.. (1994). The role of nm23 in transforming growth factor beta 1-mediated adherence and growth arrest.. PubMed. 5(9). 909–17. 24 indexed citations
11.
Schnee, Charles L., et al.. (1994). Carcinoid Tumor of the Sacrum. Neurosurgery. 35(6). 1163???1167–1163???1167. 3 indexed citations
12.
Johnson, Mark D., et al.. (1991). Reduced G protein function in desensitized rat aorta.. Journal of Pharmacology and Experimental Therapeutics. 259(1). 255–259. 18 indexed citations
13.
Huang, Paul P., et al.. (1991). Myelination of the rat retina by transplantation of oligodendrocytes into 4-day-old hosts. Experimental Neurology. 113(3). 291–300. 22 indexed citations
14.
Buset, Michel, P. Galand, Mack Lipkin, Sidney J. Winawer, & E Friedman. (1990). Injury induced by fatty acids or bile acid in isolated human colonocytes prevented by calcium. Cancer Letters. 50(3). 221–226. 12 indexed citations
15.
Infante, Diógenes, et al.. (1990). Transforming growth factor beta 1 acts as an autocrine-negative growth regulator in colon enterocytic differentiation but not in goblet cell maturation.. PubMed. 1(12). 617–26. 85 indexed citations
16.
Schroy, Paul C., et al.. (1990). Role of transforming growth factor beta 1 in induction of colon carcinoma differentiation by hexamethylene bisacetamide.. PubMed. 50(2). 261–5. 71 indexed citations
17.
Lipkin, Mack, E Friedman, Sidney J. Winawer, & H L Newmark. (1989). Colonic epithelial cell proliferation in responders and nonresponders to supplemental dietary calcium.. PubMed. 49(1). 248–54. 104 indexed citations
18.
Schroy, Paul C., Sidney J. Winawer, & E Friedman. (1989). Effect on in vivo tumorigenicity of lengthy exposure of human colon cancer cells to the differentiation agent hexamethylene bisacetamide. Cancer Letters. 48(1). 53–58. 7 indexed citations
19.
Friedman, E, Charles J. Lightdale, & Sidney J. Winawer. (1988). Effects of psyllium fiber and short-chain organic acids derived from fiber breakdown on colonic epithelial cells from high-risk patients. Cancer Letters. 43(1-2). 121–124. 12 indexed citations
20.
Friedman, E, Michael F. Verderame, Mack Lipkin, & Robert Pollack. (1985). Paradigm of actin cable loss does not apply to human colon tumor development. Proceedings of the American Association for Cancer Research. 26. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026